Pliant Therapeutics (PLRX) Revenue (2020 - 2023)

Pliant Therapeutics (PLRX) has reported Revenue for 4 consecutive years, with $248000.0 the latest figure, recorded in Q2 2023.

• On a quarterly basis, Revenue fell 95.03% year-over-year to $248000.0 in Q2 2023; TTM through Mar 2024 was $248000.0, a 97.46% decrease from a year earlier, with the FY2023 full-year figure at $1.6 million, down 83.69% from the prior year.
• Revenue was $248000.0 for Q2 2023 at Pliant Therapeutics, down from $1.3 million in the prior quarter.
• Over five years, Revenue peaked at $28.9 million in Q1 2020 and troughed at $248000.0 in Q2 2023.
• A 4-year average of $4.3 million and a median of $2.0 million in 2021 frame the typical range for Revenue.
• Across the five-year window, Revenue jumped 178.87% in 2022 and sank 95.03% in 2023, its largest moves.
• Over 4 years, Revenue stood at $4.4 million in 2020, then slumped by 54.74% to $2.0 million in 2021, then slipped by 1.7% to $2.0 million in 2022, then plunged by 87.38% to $248000.0 in 2023.
• The last three Revenue figures came in at $248000.0 (Q2 2023), $1.3 million (Q1 2023), and $2.0 million (Q4 2022), per Business Quant data.